TC-1 tumor-bearing mice s.c. received either rlipoE7m or rlipoE7m-MoGM and showed no significant differences in the percentages of CD4+ T cells in either the TdLNs (figure 7A) or tumors (figure 7B). The gene discussed is CD4; the disease is neoplasm.